Transfusion-related acute lung injury

A thrombotic thrombocytopenic purpura treatment-associated case report and concise review

Julie Cruz, Elaine Skipworth, Deborah Blue, Dan Waxman, Leo McCarthy, Daniel Smith

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Blood products are frequently required immediately prior to, during, or just after an apheresis procedure. Transfusion-related acute lung injury (TRALI) is now the leading cause of transfusion-related mortality, surpassing ABO-incompatible hemolytic reactions. The reported incidence of TRALI varies but is estimated at 1 in 5,000 transfusions. The true incidence could be higher because of under-reporting and under-diagnosis. Plasma is the most frequently implicated blood product. While the pathogenesis of TRALI appears multifactorial, one contributing factor seems to be donor antibodies to cognate recipient neutrophil antigens. Biologically active neutrophil-priming substances may also play a role. New diagnostic criteria have recently been proposed to aid in the diagnosis of TRALI. We report a thrombotic thrombocytopenic purpura (TTP) treatment-associated case of TRALI and review the history, pathogenesis, diagnosis and management of this syndrome. Current risk reduction strategies are also discussed.

Original languageEnglish
Pages (from-to)96-103
Number of pages8
JournalJournal of Clinical Apheresis
Volume23
Issue number2
DOIs
StatePublished - 2008

Fingerprint

Thrombotic Thrombocytopenic Purpura
Acute Lung Injury
Neutrophils
Therapeutics
Blood Component Removal
Incidence
Risk Reduction Behavior
History
Antigens
Mortality
Antibodies

Keywords

  • Plasma
  • TRALI
  • Transfusion reaction
  • TTP

ASJC Scopus subject areas

  • Hematology

Cite this

Transfusion-related acute lung injury : A thrombotic thrombocytopenic purpura treatment-associated case report and concise review. / Cruz, Julie; Skipworth, Elaine; Blue, Deborah; Waxman, Dan; McCarthy, Leo; Smith, Daniel.

In: Journal of Clinical Apheresis, Vol. 23, No. 2, 2008, p. 96-103.

Research output: Contribution to journalArticle

Cruz, Julie ; Skipworth, Elaine ; Blue, Deborah ; Waxman, Dan ; McCarthy, Leo ; Smith, Daniel. / Transfusion-related acute lung injury : A thrombotic thrombocytopenic purpura treatment-associated case report and concise review. In: Journal of Clinical Apheresis. 2008 ; Vol. 23, No. 2. pp. 96-103.
@article{ce8e6d6f728f4ae68b407bec49eccf2c,
title = "Transfusion-related acute lung injury: A thrombotic thrombocytopenic purpura treatment-associated case report and concise review",
abstract = "Blood products are frequently required immediately prior to, during, or just after an apheresis procedure. Transfusion-related acute lung injury (TRALI) is now the leading cause of transfusion-related mortality, surpassing ABO-incompatible hemolytic reactions. The reported incidence of TRALI varies but is estimated at 1 in 5,000 transfusions. The true incidence could be higher because of under-reporting and under-diagnosis. Plasma is the most frequently implicated blood product. While the pathogenesis of TRALI appears multifactorial, one contributing factor seems to be donor antibodies to cognate recipient neutrophil antigens. Biologically active neutrophil-priming substances may also play a role. New diagnostic criteria have recently been proposed to aid in the diagnosis of TRALI. We report a thrombotic thrombocytopenic purpura (TTP) treatment-associated case of TRALI and review the history, pathogenesis, diagnosis and management of this syndrome. Current risk reduction strategies are also discussed.",
keywords = "Plasma, TRALI, Transfusion reaction, TTP",
author = "Julie Cruz and Elaine Skipworth and Deborah Blue and Dan Waxman and Leo McCarthy and Daniel Smith",
year = "2008",
doi = "10.1002/jca.20158",
language = "English",
volume = "23",
pages = "96--103",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Transfusion-related acute lung injury

T2 - A thrombotic thrombocytopenic purpura treatment-associated case report and concise review

AU - Cruz, Julie

AU - Skipworth, Elaine

AU - Blue, Deborah

AU - Waxman, Dan

AU - McCarthy, Leo

AU - Smith, Daniel

PY - 2008

Y1 - 2008

N2 - Blood products are frequently required immediately prior to, during, or just after an apheresis procedure. Transfusion-related acute lung injury (TRALI) is now the leading cause of transfusion-related mortality, surpassing ABO-incompatible hemolytic reactions. The reported incidence of TRALI varies but is estimated at 1 in 5,000 transfusions. The true incidence could be higher because of under-reporting and under-diagnosis. Plasma is the most frequently implicated blood product. While the pathogenesis of TRALI appears multifactorial, one contributing factor seems to be donor antibodies to cognate recipient neutrophil antigens. Biologically active neutrophil-priming substances may also play a role. New diagnostic criteria have recently been proposed to aid in the diagnosis of TRALI. We report a thrombotic thrombocytopenic purpura (TTP) treatment-associated case of TRALI and review the history, pathogenesis, diagnosis and management of this syndrome. Current risk reduction strategies are also discussed.

AB - Blood products are frequently required immediately prior to, during, or just after an apheresis procedure. Transfusion-related acute lung injury (TRALI) is now the leading cause of transfusion-related mortality, surpassing ABO-incompatible hemolytic reactions. The reported incidence of TRALI varies but is estimated at 1 in 5,000 transfusions. The true incidence could be higher because of under-reporting and under-diagnosis. Plasma is the most frequently implicated blood product. While the pathogenesis of TRALI appears multifactorial, one contributing factor seems to be donor antibodies to cognate recipient neutrophil antigens. Biologically active neutrophil-priming substances may also play a role. New diagnostic criteria have recently been proposed to aid in the diagnosis of TRALI. We report a thrombotic thrombocytopenic purpura (TTP) treatment-associated case of TRALI and review the history, pathogenesis, diagnosis and management of this syndrome. Current risk reduction strategies are also discussed.

KW - Plasma

KW - TRALI

KW - Transfusion reaction

KW - TTP

UR - http://www.scopus.com/inward/record.url?scp=43249086454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43249086454&partnerID=8YFLogxK

U2 - 10.1002/jca.20158

DO - 10.1002/jca.20158

M3 - Article

VL - 23

SP - 96

EP - 103

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 2

ER -